Skip to main content

Table 4 Multivariate adjusted odds ratios (OR) and 95 % confidence intervals (CI) of HER2-positive and HER2-negative invasive cancer associated with caspase-8 polymorphisms

From: Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study

SNP

HER2-positive

HER2-negative

Unadjusted

Adjusteda

Unadjusted

Adjusteda

OR

95 % CI

p**

OR*

95 % CI

p**

OR

95 % CI

p**

OR*

95 % CI

p**

rs12693932

1.111

0.879

1.404

 

1.110

0.870

1.410

 

1.123

0.983

1.281

 

1.150

1.000

1.320

 

rs6745051

1.148

0.908

1.450

 

1.150

0.900

1.460

 

1.095

0.959

1.249

 

1.120

0.980

1.280

 

rs3769825

1.153

0.915

1.455

 

1.180

0.930

1.490

 

1.164

1.020

1.327

0.024

1.200

1.050

1.370

0.008

rs11899004

1.680

1.259

2.241

0.0004

1.620

1.210

2.180

0.0014

1.118

0.930

1.344

 

1.130

0.940

1.360

 

rs6736233

1.959

1.332

2.881

0.001

1.890

1.270

2.810

0.0017

1.283

0.995

1.655

 

1.290

0.990

1.670

 

rs1861270

0.983

0.758

1.275

 

1.050

0.800

1.370

 

1.098

0.952

1.268

 

1.150

0.990

1.330

 

rs6723097

1.336

1.057

1.688

0.015

1.410

1.110

1.800

0.0055

1.170

1.025

1.337

0.020

1.220

1.070

1.400

0.004

rs2293554

1.945

1.341

2.822

0.001

1.980

1.340

2.920

0.0005

1.165

0.910

1.490

 

1.200

0.930

1.550

 

rs1045485

0.852

0.572

1.268

 

0.810

0.540

1.220

 

1.072

0.872

1.317

 

1.030

0.830

1.270

 

rs1035140

0.958

0.760

1.207

 

1.000

0.790

1.270

 

1.081

0.950

1.231

 

1.100

0.970

1.260

 

rs700636

1.012

0.802

1.276

 

1.080

0.850

1.380

 

1.076

0.944

1.226

 

1.110

0.970

1.270

 

rs1679181

1.048

0.831

1.323

 

0.990

0.780

1.260

 

0.910

0.798

1.039

 

0.890

0.780

1.020

 
  1. aPer-allele ORs. Models were adjusted for center, age, family history, BMI, recent physical activity, alcohol consumption, and menopause/HT status
  2. **Only uncorrected p values <0.05 are listed; after correcting for multiple comparisons, only rs2293554 was statistically significantly associated with HER2-positive breast cancer risk